Symrise gets new consumer unit
This article was originally published in The Tan Sheet
Executive SummaryFood and cosmetic ingredient manufacturer Symrise expands its portfolio by adding a consumer health business unit to include food supplements, health care and specialty products, the Holzminden, Germany-based firm says Nov. 24. The unit, headed by Dirk Bennwitz, senior VP of business consumer health, "will specialize in creating functional ingredients for food supplements and flavor solutions for health products," the firm said. Symrise's consumer health team will be a driving force in the corporation's health and nutrition strategy. Symrise CEO Heinze-Jürgen Bertram said the launch of the consumer unit is in response to the growing health and nutrition market
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.